Healthcare giant Eli Lilly ... Cancer Center saw five of the nine triple-negative breast cancer patients enrolled in "Lilly’s ...

Lilly has made an upfront payment of $50 million and has taken an equity investment of €45 million in the company, and hopes the move will help it be in the vanguard of the next wave of cancer ...

Magnet Biomedicine announced Friday it has reached a licensing agreement worth up to $1.25B with Eli Lilly (NYSE:LLY) to ...

Eli Lilly’s cancer drug Cyramza has inched closer to a new indication in first-line non-small cell lung cancer (NSCLC), after a narrow vote in favour of approval by FDA advisors. The 6-5 vote by ...